Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health (NIH) plans to issue a Notice of Funding Opportunity (NOFO) aimed at supporting United States small business concerns through the Small Business Technology Transfer (STTR) Phase I and Fast-Track grant programs. This initiative, titled the Small Business Transition Grant for New Entrepreneurs, targets early-career scientists who are transitioning to entrepreneurship. The program not only funds research and development activities but also emphasizes entrepreneurial training, mentoring, and career development for the principal investigator. The opportunity is designed to foster collaboration with industry mentors, requiring that key personnel include a committed mentor to support project success. While applications are not currently being solicited, the NIH is providing advance notice to give potential applicants ample time to prepare competitive proposals. Eligible U.S. small businesses with relevant research capabilities aligned with NIH’s mission are encouraged to consider applying. This funding opportunity will use the R41/R42 activity codes and welcomes first-time principal investigators. The NIH SEED Office of Extramural Research will serve as the point of contact for inquiries. This program represents a significant opportunity for small businesses to access funding and entrepreneurial resources to advance innovative biomedical research into commercial applications.

General Info

NIH offers STTR Phase I grants supporting early-career scientists with mentoring and entrepreneurial training.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUSA
Contacts
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

The National Institutes of Health (NIH), including the participating Institutes, Centers and Offices, intends to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I, and Fast-Track grant applications for the Small Business Transition Grant. Through this NOFO, NIH will support early-career scientists transitioning to entrepreneurship. In addition to funding research and development efforts at the SBC, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects, including identification of complementary industry mentors and career development resources. This NOFO will utilize the R41/R42 activity code. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components identified in this NOFO are encouraged to begin to consider applying for this new NOFO. This opportunity is available to first-time Principal Investigators, and key personnel must include a mentor with measurable effort committed to the project. 

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Notice of Intent to Sole Source - Gut Microbiome DNA Sequencing Services
Solicitation # 1232SA26Q1371
The Department of Agriculture, specifically the USDA Ars Afm Apd, has issued a special notice of intent to sole source a contract for Gut Microbiome DNA Sequencing Services under solicitation number 1232SA26Q1371. This procurement falls under NAICS code 541714 and is not subject to any specific set-aside restrictions. The notice was posted on August 25, 2026, with a response deadline of September 1, 2026. The place of performance is located in Pennsylvania, and the primary point of contact for this opportunity is Frank Palmer.
USDA Ars Afm Apd

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Firefox Proposers Day
Solicitation # DARPA-SN-26-112
The Biological Technologies Office of DARPA is hosting an in-person Proposer Day on September 1, 2026, at the DARPA Conference Center in Arlington, Virginia, to support the upcoming Firefox Program solicitation. The event runs from 9:00 AM to 5:00 PM Eastern Daylight Time and is mandatory for attendance, with no virtual options available. Each organization is limited to three attendees, and advance registration is required with a deadline of August 21, 2026. The solicitation number is DARPA-SN-26-112, and it falls under NAICS code 541714, indicating research and development in the physical, engineering, and life sciences. Proposers are directed to contact Dr. Pedro Irazoqui at Firefox@darpa.mil for inquiries, and all times referenced in the announcement and registration materials are in Eastern Daylight Time.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 16 days
View Details
NAICS: 541714
New
Federal
Local Technical Support and Installation ServicesThis subcontract involves the on-site installation, calibration, and integration of the Opentrons Flex system for the National Oceanic and Atmospheric Administration within the Department of Commerce. The scope of work includes comprehensive system validation and user training to ensure the equipment is fully operational at the federal research laboratory located in zip code 20746. The opportunity was posted on August 24, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541714, the project focuses on providing specialized local technical support and installation services to facilitate the successful deployment of the laboratory system.
National Oceanic And Atmospheric Administration

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 541714
New
Federal
Predictive Model Development for Sepsis or Antimicrobial ResistanceThis subcontract opportunity with the National Institutes of Health Olao under the Department of Health and Human Services focuses on the development and validation of predictive models for the early detection of sepsis or antimicrobial resistance. The project requires the use of longitudinal patient data derived from real-world sources to improve diagnostic capabilities. The work is designated under NAICS code 541714 and is to be performed in Bethesda, Maryland. Interested parties must submit their responses by August 28, 2026, at 4:00 PM.
National Institutes Of Health Olao

POSTED

2 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
SBIR / STTR
Export-Controlled Technology Development (ITAR/EAR Compliance)This subcontract opportunity with the U.S. Army under the Department of Defense focuses on research and development involving export-controlled technologies. The project requires strict adherence to ITAR and EAR regulations, specifically regarding the acquisition of necessary licenses and the proper disclosure of foreign nationals involved in the work. The opportunity is a total small business set-aside under NAICS code 541714, specifically mandated for SBIR/STTR participants with fewer than 500 employees. Interested parties must submit their responses by September 11, 2026, at 4:00 PM.
U.S. Army

POSTED

2 days ago

DEADLINE

in 16 days
View Details
NAICS: 541714
New
Federal
AN13--Intent to sole source - Miniaturized CO2 Sensor Prototype Development and Novel Physiologic Gas Monitoring Research
Solicitation # 36C24E26Q0110
The Department of Veterans Affairs RPO-E R&D intends to award a sole source Firm Fixed Price contract to the University of Michigan for the development of a miniaturized CO2 sensor prototype and research into novel physiologic gas monitoring. This notice serves as a public announcement of the intent to sole source under specific federal acquisition regulations and is not a request for proposals or quotations. Interested parties may submit capability information to demonstrate their ability to meet the requirements described in the statement of work by 10:00am EST on September 8, 2026. The government will review these submissions solely to determine if a competitive procurement is necessary. All inquiries and capability statements must be emailed to Contracting Officer Renee Kale, as telephone inquiries will not be accepted.
Rpo East (36C24E)

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting offers for pilot chamber testing facilities capable of conducting hypobaric Decompression Sickness (DCS) studies under solicitation number 80JSC026Q0006, issued as a combined synopsis and solicitation per FAR Part 12 for commercial products and services. The requirement calls for three test days of data collection and recording following established research protocols, with detailed specifications outlined in Attachment A – Statement of Work and additional submission criteria in Attachment D dated July 15, 2026. The solicitation is open to all responsible sources without set-aside restrictions, and offerors must declare their size status under NAICS code 541714 with a 1,000-employee size standard. Evaluation of proposals will prioritize technical acceptability, followed by past performance, and then price, as specified in FAR 52.212-2. Offers must comply with applicable clauses including FAR 52.212-1, 52.212-2, and 52.212-4, as well as NASA-specific clauses such as the Ombudsman provision. All submissions must be delivered electronically to Tracy.L.Quintanilla@nasa.gov and Katelyn.R.Jaime@nasa.gov no later than August 24, 2026, at 1:00 p.m. Central Time. Questions must be submitted via email by July 29, 2026, same time, with no telephone inquiries accepted. Prospective offerors are encouraged to notify the point of contact of their intent to respond, and it is the offeror’s responsibility to download all documents from SAM.gov and ensure timely submission, as late or incomplete offers will be rejected in accordance with FAR provisions.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 15 days
View Details
NAICS: 541714
New
Federal
Bridge Contract - Disease Surveillance and Research Support
Solicitation # PANDHA-26-P-0000-047373
The Defense Health Agency Contracting Activity intends to negotiate a 12-month sole source bridge contract with The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. This agreement enables the Walter Reed Army Institute of Research to provide critical surveillance and research services focused on the assessment of infectious diseases across the African continent, specifically targeting regions including Ethiopia, Kenya, Nigeria, Somalia, Tanzania, and Uganda. The procurement, identified by solicitation number PANDHA-26-P-0000-047373 and NAICS code 541714, is being conducted under the authority of 10 United States Code 3204(a)(1) and FAR 6.103-1(c)(2)(ii). The notice was posted on August 21, 2026, with a response deadline of September 4, 2026. There is no set-aside designated for this requirement.
Defense Health Agency

POSTED

5 days ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
SBIR / STTR
Radiation Defect Mitigation R&D for Ultrathin Silicon Solar Cells
NASA SBIR/STTR Program

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
Skin commensal sequencing
Solicitation # 75N98026Q01038
The National Institutes of Health intends to award a non-competitive contract for skin commensal sequencing to SeqCoast Genomic LLC. This procurement, identified by synopsis number 75N98026Q01038, falls under NAICS code 541714 and is being conducted via Simplified Acquisition Procedures for an amount not exceeding 350,000 dollars. The project supports the laboratory of Julie Segre in studying the human skin microbiome by extracting and sequencing genomes of skin commensal organisms to streamline workflows and reduce costs for ongoing research. Interested parties must submit their capabilities, including a technical and cost-price proposal, by August 31, 2026, at 9:00 AM Eastern time. All submissions must be sent electronically to the contracting officer and require an active registration in the System for Award Management. While the government intends to proceed on a non-competitive basis, it will review submitted capability statements to determine if a competitive procurement is necessary.
National Institutes Of Health Olao

POSTED

7 days ago

DEADLINE

in 5 days
View Details
NAICS: 541714
Federal
Nanobody against NPR-C for growth disorder
Solicitation # 75N98026Q01031
This project focuses on the development of high-affinity and specific VHH nanobodies against human NPR-C to create potential therapeutics for growth disorders like achondroplasia. The scope of work involves two possible development tracks: phage/yeast display using immunized libraries or single B-cell cloning. The process includes antigen generation, alpaca or llama immunization, library construction or B-cell isolation, and rigorous screening and sequencing to identify unique clones. The final goal is to produce and characterize at least 10 unique VHH-Fc candidates with a target affinity of KD=10nM or better, ensuring no cross-reactivity with NPR-B. The project is expected to be completed within four to six months, with deliverables including serum titer reports, sequence data, purified antibodies, and a final summary report. The NIH retains all intellectual property ownership of the resulting antibodies and data. Out of scope activities include humanization, affinity maturation, GMP manufacturing, and stable cell line development. The contract follows a milestone-based payout structure and requires vendors to comply with IACUC-equivalent animal welfare standards.
National Institutes Of Health Olao

POSTED

8 days ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)The National Institute on Minority Health and Health Disparities within the National Institutes of Health is issuing a forecast for planning grants titled Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes. These grants are designed to support preparatory, feasibility, and pilot activities that advance intervention development or solutions-oriented etiologic studies. A mandatory requirement for all projects is that they must be co-developed with community partners to ensure the effectiveness of the health outcomes being addressed. Priority areas for funding include formative studies on understudied contributors to chronic diseases like cancer and diabetes, as well as the adaptation and pilot-testing of interventions for maternal and infant health. Additionally, the program seeks feasibility and acceptability testing for strategies aimed at reducing behavioral risk factors, such as poor nutrition and smoking, to promote sustained behavior change and measurable improvements in health for NHPI populations.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 334510
New
Grant
Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources (S15 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, has issued a forecast for the Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources program. This funding opportunity is designed for eligible shared biomedical research facilities, such as core facilities, biorepositories, and model resource facilities, to acquire new small instruments or scientific equipment. The primary objective is to enhance the operational efficiency and capabilities of resources shared by multiple researchers. Priority is given to requests for small instruments utilizing emerging technologies or those that generate physical, chemical, or biomaterial outputs rather than standard digital data. It is important to note that funding is restricted and cannot be used for building-level infrastructure or highly specialized instruments that only indirectly support research. Clinical trials are not allowed under this specific opportunity.
Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2The National Institutes of Health, through the National Institute on Drug Abuse, is forecasting Phase 2 of the Single Cell Opioid Responses in the Context of HIV (SCORCH) program. This initiative builds upon Phase 1 research by utilizing single-nucleus datasets from human and animal postmortem brain tissue to investigate the interactions between Substance Use Disorder and HIV disease progression within the Central Nervous System. The program aims to employ advanced single cell approaches, including the study of RNA splicing, epigenomic features, and spatial interactions, to conduct both data mining and hypothesis-driven research. The ultimate goal is to enhance the mechanistic understanding of how these conditions affect the brain at subcellular and circuit levels to identify potential targets for novel therapeutic interventions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Translational Research in Maternal and Pediatric Pharmacology and TherapeuticsThe National Institutes of Health, through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, intends to issue a Notice of Funding Opportunity for translational research in maternal and pediatric pharmacology and therapeutics. This initiative aims to improve safe and effective precision therapeutics for pregnant women, lactating women, infants, children, and adolescents. The program focuses on advancing precision medicine via novel tools and technologies, developing safer therapeutics, improving patient-provider communication regarding drug safety, and scaling evidence-based interventions. This forecast is part of the agency's stewardship of the Best Pharmaceuticals for Children Act and recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women. While the project outlines clear goals for enhancing medication effectiveness and safety across these specific patient populations, applications are not currently being solicited. Interested parties can coordinate with the Obstetric and Pediatric Pharmacology and Therapeutics Branch for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC)The Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) is a legislatively mandated Centers of Excellence program managed by the National Institutes of Health under the Department of Health and Human Services. This initiative focuses on expanding and intensifying basic, translational, and clinical research regarding muscular dystrophy through interdisciplinary collaboration and shared resources. By supporting innovative center-based projects and providing robust training environments for emerging scientists, the program aims to achieve research outcomes that exceed the capabilities of stand-alone grants. A critical component of the program is its commitment to patient-centered research, actively engaging patient and advocacy communities to increase awareness and ensure that study designs are informed by patient perspectives. This forecast opportunity is supported by several grant authorities, including 42 U.S.C. 281, 283g, 285g, and 284h. Interested parties can coordinate with the NICHD Intellectual and Developmental Disabilities Branch for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is seeking a coordinated, milestone-driven research project titled Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes. This initiative aims to integrate large, longitudinal, and multimodal datasets from various T1D research consortia to examine how different biological processes, tissues, and organs interact to drive the development and progression of the disease. By combining human pancreas and clinical data, the project seeks to uncover new insights into T1D biology, identify biomarkers, and inform personalized approaches for prevention and treatment. To achieve these goals, the project will focus on the development and testing of advanced multimodal AI models and AI-enabled research workflows. Key technical objectives include creating new methods for data integration and generating privacy-preserving synthetic datasets. This effort is designed to move beyond the limitations of individual studies to provide a comprehensive understanding of the different forms and stages of Type 1 Diabetes, ultimately accelerating the advancement of precision medicine.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)The National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to provide continued support for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on conducting clinical trials to improve outcomes for patients experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings by identifying effective early-stage treatments. The program specifically seeks to establish a Clinical Coordinating Center (CCC) and a Data Coordinating Center (DCC) to support the network's infrastructure. While this notice serves as a forecast to allow potential applicants time to form collaborations and prepare responsive applications, formal solicitations are not currently being accepted.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 611430
Grant
Mentored Career Transition Award (KT1/R00)The Mentored Career Transition Award (KT1/R00), issued by the National Institutes of Health under the Department of Health and Human Services, is a biphasic grant designed to transition postdoctoral researchers into independent, tenure-track faculty roles. The award provides up to five years of total support, beginning with a mentored career development phase lasting one to two years. The second phase offers up to three years of independent research funding, which is contingent upon the recipient's satisfactory progress during the initial phase and the procurement of an approved, research-intensive faculty position. This forecasted opportunity is managed by the Division of Biomedical Research Workforce.
Professional and Management Development Training

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 621910
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment HubsThe National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to support the infrastructure for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on establishing clinical enrollment hubs to conduct trials aimed at improving outcomes for individuals experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings. This notice serves as a forecast to allow potential applicants time to establish collaborations and develop responsive applications. While the program aims to identify effective early-stage treatments, applications are not currently being solicited. Interested parties can contact the NINDS Department of Emergency Medicine for further information.
Ambulance Services

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Mentored Research Scientist Career Development Award (KR1)The Mentored Research Scientist Career Development Award (KR1), issued by the National Institutes of Health under the Department of Health and Human Services, is designed to support candidates with research doctoral degrees in their pursuit of future research independence. The award provides up to five years of protected time for intensive career development under the guidance of an experienced mentor. This opportunity is currently listed as a forecast with a posted date of August 13, 2026. Interested parties can contact the Division of Biomedical Research Workforce via email at nihtrain@mail.nih.gov for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details